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Methylmercury (MeHg) is a very reactive
organometal compound. Exposure especially
affects the nervous system. Hence, low-level
exposure during pregnancy may cause
impaired development in infants and children
(National Research Council 2000). In most
populations, ﬁsh is the major source of MeHg
(International Programme on Chemical Safety
1990). The elimination half-time of MeHg
varies greatly among individuals, ranging from
45 to 70 days (Clarkson 2002), but extreme
values, up to almost 190 days, have been
reported (Al-Shahristani and Shihab 1974).
One explanation of this variation might be
hereditary differences in MeHg metabolism.
MeHg is eliminated in the bile as a gluta-
thione (GSH) conjugate (Ballatori and
Clarkson 1985; Dutczak and Ballatori 1994),
and polymorphisms in GSH-synthesizing or
GSH-conjugating enzymes may thus influ-
ence the elimination capacity. The rate-
limiting enzyme for GSH synthesis is
glutamyl-cysteine ligase (GCL), which is com-
posed of a catalytic subunit [GCLC; Unigene
accession no. Hs.654465; National Center for
Biotechnology Information (NCBI) Unigene
Database 2006b] and a modifier subunit
(GCLM; Unigene accession no. Hs.315562).
Polymorphisms affecting GSH production
(lower promoter activity for the variant alleles)
have been found in both subunits: a C→T
nucleotide substitution at position –129 in
GCLC (GCLC-129) (Koide et al. 2003) and a
C→T nucleotide substitution at position
–588 in GCLM (Nakamura et al. 2002).
The glutathione S-transferases (GSTs),
which conjugate GSH to a wide variety of
electrophilic compounds (Hayes and Strange
2000; Strange and Fryer 1999), may also
affect the metabolism of MeHg. The GST
family comprises several genes, many of which
are polymorphic in humans. Glutathione S-
transferase pi 1 (GSTP1; Unigene accession
no. Hs.523836) exhibits a number of varia-
tions, of which the Ile105Val and Ala114Val
amino acid substitutions both are associated
with differences in enzyme activity and sub-
strate preferences (Ali-Osman et al. 1997;
Sundberg et al. 1998; Zimniak et al. 1994).
In a recent study by our group (Custodio
et al. 2005), individuals with one variant allele
for either GCLC-129 or GSTP1-114 were
found to have a higher retention of mercury
in erythrocytes (Ery-Hg) compared with indi-
viduals with other genotypes but similar expo-
sure [level of long-chain n-3 polyunsaturated
fatty acids in plasma (P-PUFA) was used as a
proxy for ﬁsh consumption/MeHg exposure].
A limitation of that study was that most sub-
jects had low levels of ﬁsh consumption, and
thereby low Ery-Hg. The aim for this study
was to further investigate the associations
between Ery-Hg and GSH-related genotypes
at higher MeHg exposures. For this purpose,
we chose polymorphisms in the three genes,
for which effects on Hg retention have been
seen for either MeHg (GCLC and GSTP1) or
inorganic Hg (GCLM) (Custodio et al. 2004).
Materials and Methods
Study population. The study subjects were
selected from the Västerbotten Intervention
Program (VIP) cohort. VIP is a long-term pro-
ject intended for health promotion of the
population of Västerbotten, a county in north-
ern Sweden. Since 1985, all individuals at 40,
50, and 60 years of age in the population of
the county were invited for screening, and the
cohort included 94,630 sampling occasions
from 74,690 unique individuals by June 2006.
Blood samples were taken from the VIP
cohorts in a uniform way after an overnight
fasting period, and the samples were stored as
plasma, erythrocytes, or buffy coat at –80°C.
The survey procedures are detailed elsewhere
(Hallmans et al. 2003). The study subjects
filled out a health/lifestyle questionnaire
(Johansson et al. 2002), and a random sample
of 300 individuals was chosen from among
individuals consuming ﬁsh at least 2.5 times a
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BACKGROUND: Exposure to toxic methylmercury (MeHg) through ﬁsh consumption is a large prob-
lem worldwide, and it has led to governmental recommendations of reduced ﬁsh consumption and
blacklisting of mercury-contaminated ﬁsh. The elimination kinetics of MeHg varies greatly among
individuals. Knowledge about the reasons for such variation is of importance for improving the risk
assessment for MeHg. One possible explanation is hereditary differences in MeHg metabolism.
MeHg is eliminated from the body as a glutathione (GSH) conjugate.
OBJECTIVES: We conducted this study to assess the inﬂuence of polymorphisms in GSH-synthesizing
[glutamyl-cysteine ligase modiﬁer subunit (GCLM-588) and glutamyl-cysteine ligase catalytic subunit
(GCLC-129)] or GSH-conjugating [glutathione S-transferase pi 1 (GSTP1-105 and GSTP1-114)]
genes on MeHg retention. 
METHODS: Based on information obtained from questionnaires, 292 subjects from northern
Sweden had a high consumption of ﬁsh (lean/fat ﬁsh two to three times per week or more). We
measured total Hg in erythrocytes (Ery-Hg) and long-chain n-3 polyunsaturated fatty acids in
plasma (P-PUFA; an exposure marker for ﬁsh intake). 
RESULTS: The GSTP1 genotype modiﬁed Ery-Hg; effects were seen for GSTP1-105 and -114 sepa-
rately, and combining them resulted in stronger effects. We found evidence of effect modiﬁcation:
individuals with zero or one variant allele demonstrated a steeper regression slope for Ery-Hg
(p = 0.038) compared with individuals with two or more variant alleles. The GCLM-588 genotype
also inﬂuenced Ery-Hg (p = 0.035): Individuals with the GCLM-588 TT genotype demonstrated
the highest Ery-Hg, but we saw no evidence of effect modiﬁcation with increasing P-PUFA. 
CONCLUSIONS: These results suggest a role of GSH-related polymorphisms in MeHg metabolism.
KEY WORDS: GCLC, GCLM, GSTP1, metabolism, methylmercury, polymorphism. Environ Health
Perspect 116:734–739 (2008). doi:10.1289/ehp.10804 available via http://dx.doi.org/ [Online
14 February 2008]week (2,648 individuals in total). The individ-
uals were matched to our previous study for
age and sex. Among these, we had erythrocytes
and DNA samples for 292 individuals. The
mean age was 49 years, with a range of
29–61 year. Of this group, 207 individuals
(71%) were male and 85 (29%) were female.
The samples were collected between 1992 and
2002. The study was approved by the Regional
Ethics Committee of Umeå University.
We complied with all applicable require-
ments of the United States and international
regulations (including institutional review
board approval). Participants gave written
informed consent before the study.
Measurement of Ery-Hg and P-PUFA.
We determined Ery-Hg in acid-digested sam-
ples using cold vapor atomic fluorescence
spectrometry (Sandborgh-Englund et al.
1998). The limit of detection, calculated as
3 × SD for the blanks, was 0.10 µg/L. All
samples were prepared in duplicate, and the
method imprecision (calculated as the coefﬁ-
cient of variation for duplicate preparations
measurements) was 3.7%. The analytical
accuracy was checked against reference mater-
ial, consisting of certiﬁed human blood sam-
ples (lot M0401 and M0407) obtained from
the Centre de Toxicologie du Quebec,
International Comparison Program, Quebec,
Quebec, Canada). The results obtained were
1.8 ± 0.10 µg/L (mean ± SD; lot M0401) and
9.2 ± 0.26 µg/L (lot M0407) versus certiﬁed
2.0 and 9.4 µg/L, respectively. 
Plasma fatty acids were separated by gas–
liquid chromatography after separation of the
lipids by thin-layer chromatography and
transmethylation, as described elsewhere
(Boberg et al. 1985). The relative amounts of
the fatty acids were expressed as a percentage
of all fatty acids analyzed. We calculated
P-PUFA as the fraction of (%) eicosapen-
taenoic acid (20:5 n-3) and docosahexaenoic
acid (22:6 n-3) in plasma phospholipids,
which are closely associated with fish intake
(Hallgren et al. 2001; Svensson et al. 1993).
Genotype analyses. We used the Taqman
allelic discrimination assay (ABI 7000;
Applied Biosystems, Foster City, CA, USA) to
analyze separately all four single nucleotide
polymorphisms (SNPs): GCLC-129, GCLM-
588, GSTP1-105, and GSTP1-114. The
primers and probes have been described previ-
ously (Custodio et al. 2005). Each real-time
polymerase chain reaction (PCR) assay (except
for GSTP1-114) was performed with a reac-
tion volume of 25 µL containing 1× Universal
Taqman mix (Applied Biosystems), 5 ng
DNA, 0.9 µM of each primer, and 0.2 µM of
each probe, with the following program: 50°C
for 2 min and 95°C for 10 min, followed by
40 cycles of 95°C for 15 sec and 60°C for
1 min. The GSTP1-114 reaction contained
1U   Taq polymerase (Taq Platinum;
Invitrogen, Carlsbad, CA, USA), 1× PCR
buffer, 2.5 mM MgCl2, 0.8 mM dNTP
(Amersham Biosciences, Piscataway, NJ,
USA), 1× ROX (6-carboxyl-X-rhodamine;
Invitrogen), 2 ng DNA, 1 µM of each primer,
0.08 µM of each probe, and double-distilled
water in a total volume of 25 µL, and followed
the program described above. We included
controls for each genotype in each run, and
genotyping was repeated on 5% of the sam-
ples. There was a perfect agreement between
the original and repeat genotyping runs in all
of the four SNPs analyzed.
Statistical analysis. We tested deviations
from Hardy-Weinberg equilibrium using the
Fisher-Freeman-Halton test (StatXact; Cytel
Inc., Cambridge, MA, USA). We analyzed
Spearman’s correlation (rs) to evaluate the
“strongest” exposure marker of MeHg
(P-PUFA, total ﬁsh intake, fat ﬁsh intake, or
lean ﬁsh intake). To explore effects at differ-
ent levels of exposure, subjects were divided
into three groups of equal sizes, according to
the strongest exposure marker variable.
Analysis of variance (ANOVA) techniques
were employed to analyze, within the differ-
ent exposure groups, the effects of genotype
(single gene effects, as well as combined
effects of the two GSTP1 polymorphisms) on
natural log (ln)–transformed Ery-Hg, as the
dependent variable. Because of the low num-
ber of individuals with the homozygote vari-
ant genotype, GSTP1-114 AlaVal and ValVal
were pooled (AlaVal + ValVal), as well as
GCLC-129 CT and TT (CT + TT). For the
multivariate analyses, we used only the
“strongest” exposure marker of MeHg—as in
the ANOVAs (the different exposure marker
variables were highly correlated)—as a
numerical (not categorized) independent vari-
able, with ln Ery-Hg as the dependent vari-
able. We carefully evaluated the form of
association between the exposure marker and
ln Ery-Hg variables. 
Other potentially inﬂuential independent
variables (age, sex, alcohol consumption, snuff
usage, year of sampling) were included in the
model if they had a p-value < 0.2. Variables
that did not inﬂuence the results were there-
after excluded from the model (i.e., sex,
p = 0.21; alcohol consumption, p = 0.31; and
snuffing, p = 0.78). We used a multivariate
model with an interaction term between expo-
sure and genotype to account for multiplicative
effect modiﬁcation. If no effect modiﬁcation
was present, we used a model without the
interaction term. 
We also analyzed effects of dual-gene poly-
morphisms, where genotype was defined as
the total number of variant alleles for both
genes. The effects of the genes were first
assessed separately for each genotype; geno-
types were subsequently grouped based on the
effect estimates. We used data from individu-
als with the most variant alleles as references
values. We performed post hoc tests using the
least signiﬁcant difference method to account
for comparisonwise error rate. All statistical
analyses were performed using SPSS software
(version 14; SPSS, Chicago, IL, USA).
Results
Exposure markers. Summary data for Ery-Hg,
P-PUFA, and ﬁsh consumption (total, fat, and
lean ﬁsh intake) are presented in Table 1. For
ﬁsh consumption, the correlations with Ery-
Hg were as follows: total ﬁsh, rs = 0.078, p =
0.18; fat fish, rs = 0.17, p = 0.004; and lean
ﬁsh, rs = –0.12, p = 0.036.
P-PUFA had the strongest correlation
with Ery-Hg (rs = 0.41, p < 0.001; Figure 1)
and was thus chosen as the exposure marker.
The exposure markers were strongly corre-
lated with each other: P-PUFA was positively
correlated with total fish intake (rs = 0.16,
p = 0.005) and fat fish intake (rs = 0.30,
p < 0.001), but it was negatively correlated
with lean ﬁsh intake (rs = –0.20, p < 0.001).
Hence, P-PUFA was employed as the expo-
sure marker variable. In the multivariate
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Table 1. Summary Ery-Hg and exposure data for the study population (n = 292).
Characteristic Mean Median Range
Ery-Hg (µg/L) 5.5 4.2 < LOD–40
P-PUFA (%) 6.9 6.6 3.6–16
Fish consumption (no. of meals per day)
Total 0.52 0.44  0.36–2.0
Fat ﬁsh  0.22 0.14  0–1.0
Lean ﬁsh  0.30 0.36  0.040–1.0
LOD, limit of detection.  Figure 1. Relationship between P-PUFA and Ery-Hg. 
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)analyses, P-PUFA was double log transformed
to ﬁt into linearity, which is more appropriate
for the general linear model used by SPSS.
Figures 2 and 3 clarify the changes in linearity
by P-PUFA transformations. Two more
covariates were included in the multivariate
analysis: age (rs = 0.17, p < 0.003) and year of
sampling (rs = –0.16, p < 0.004). We found a
time trend with decreasing Ery-Hg for each
year of sampling (but no similar annual
decrease in P-PUFA; data not shown).
Effect of genotype on Ery-Hg: ANOVA. The
genotype frequencies are presented in Table 2.
All genes were in Hardy-Weinberg equilibrium,
except for GCLM-588 (p < 0.001). ANOVA
results are presented in Table 3.
Glutathione-synthesizing genes (GCLM
and GCLC). No signiﬁcant results were seen
in the ANOVA results.
GSTP1. Ery-Hg was affected by genotype
only in the highest exposure group (p = 0.050),
where individuals with the ValVal allele for
GSTP1-105 had lower Ery-Hg compared with
individuals with IleIle (p = 0.046) and IleVal
(p = 0.057) genotypes. Individuals carrying at
least one Val allele for GSTP1-114 had lower
Ery-Hg compared with individuals with the
AlaAla genotype (p = 0.014).
SNP combinations. Individuals with two
or more variant alleles of either GSTP1-105 or
GSTP1-114 had lower Ery-Hg than did indi-
viduals with zero (p = 0.004) or one (p = 0.071)
variant allele. For all individuals with one vari-
ant allele in the GSTP1-105 and GSTP1-114
combination, this allele was GSTP1-105Val.
Effect of genotype on Ery-Hg: multivariate
analysis. The final model was as follows: ln
Ery-Hg = intercept + β1 × genotype + β2 × age
+ β3 × year of sampling + β4 × P-PUFA + β5
× (genotype × P-PUFA). If no effect modiﬁ-
cation was present, a model without inter-
action term was performed: ln Ery-Hg =
intercept + β1 × genotype + β2 × age + β3 ×
year of sampling + β4 × P-PUFA.
Glutathione-synthesizing genes (GCLM
and GCLC). No effects were seen in the model
with an interaction term (Table 4). Hence, we
analyzed the data in a model without an inter-
action term, where GCLM demonstrated sig-
nificant effects on Ery-Hg (p = 0.035)
(Figure 4); TT carriers had higher Ery-Hg than
did the other genotypes. Geometric means
adjusted for P-PUFA, age, and year of sam-
pling were as follows: for GCLM-588,
CC, 4.3 µL/g; CT, 3.4 µL/g; and TT,
5.5 µL/g, yielding signiﬁcant associations for
CT versus TT (p = 0.032) and CT versus CC
(p = 0.031). The association between CC ver-
sus TT carriers was nonsigniﬁcant (p = 0.22).
No significant relationships were seen for
GCLC (data not shown).
GSTP1. Effect modifications were seen
for GSTP1-105 and GSTP1-114 (Table 4).
For GSTP1-105, individuals with the Ile allele
present (i.e., zero or one of the variant Val
allele) demonstrated a steeper regression slope
for Ery-Hg. The AlaAla carriers for GSTP1-
114 followed the same pattern as the individu-
als with GSTP1-105 Ile allele present.
SNP combinations. The dual-polymor-
phism effects for GSTP1-105 and -114 were
stronger than for each gene separately (for all
individuals with one variant allele, this allele
was GSTP1-105Val) (Figure 5, Table 4). An
effect modiﬁcation was indicated for the com-
bination of GCLC-129 and GSTP1-114
(Table 4), where subjects with zero or one
variant allele demonstrated a steeper regres-
sion slope compared with individuals with
two variant alleles. A similar effect was also
seen for the combination of GCLC-129 and
GSTP1-105 (Table 4).
Discussion
Results of the present study indicate that
polymorphisms in GCLM and GST genes
Schläwicke Engström et al.
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Figure 2. Relationship between P-PUFA (ln trans-
formed) and Ery-Hg (ln transformed). 
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Figure 3. Relationship between P-PUFA (double ln
transformed) and Ery-Hg (ln transformed). 
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Table 2. Genotype frequencies for GCLC-129, GCLM-588, GSTP1-105, and GSTP1-114.
Gene Polymorphism Genotype Frequency  (%)
GCLC –129C/T CC 88
rs17883901 CT 11
TT 0.3
GCLM –588C/T CC 76
rs41303970 CT 20
TT 4
GSTP1 Ile105Val Ile/Ile 45
rs1695 Ile/Val 47
Val/Val 9
GSTP1 Ala114Val Ala/Ala 80
rs1138272 Ala/Val 19
Val/Val 1
The rs (refSNP) numbers are from the SNP Database (NCBI 2006a). 
Table 3. Ery-Hg (geometric mean) for different genotypes among the different exposure groups.
Low Intermediate High
(3.6–5.8% P-PUFA) (5.9–7.5% P-PUFA) (7.6–16% P-PUFA)
Genotype Ery-Hg No. Ery-Hg No. Ery-Hg No.
GCLC-129a
CC 2.9 83 3.9 85 5.9 90
CT + TT 3.3 14 4.1 13 7.9 7
GCLM-588
CC 3.2 74 4.0 72 6.0 75
CT 2.2 20 3.4 19 5.7 18
TT 4.6 3 5.8 5 9.0 4
GSTP1-105
IleIle 3.1 45 4.1 41 7.0* 44
IleVal 2.7 43 3.6 47 5.6 46
ValVal 3.7 9 5.2 9 4.4 7
GSTP1-114 Val alleleb
AlaAla 2.9 80 4.0 77 6.5* 75
AlaVal, ValVal 3.1 16 3.9 21 4.7 22
GSTP1-105 and GSTP1-114 
No variant alleles 3.0 44 4.1 40 7.0* 44
One variant allele 2.7 33 3.6 33 6.1 28
Two variant alleles 3.2 19 4.2 24 4.6 25
aGCLC CT and TT are pooled because of the low number of individuals with the TT genotype (n = 1). bGSTP1 AlaVal and ValVal
are pooled because of the low number of individuals with the ValVal genotype (n = 4). *p< 0.05 within the exposure group. modify the relationship between exposure to
and retention of MeHg.
Genetic influences on metal metabolism
have been established for only a few toxic
metals. ALAD (δ-aminolevulinic acid dehy-
dratase) genotype and lead exposure is the
most studied interaction; at high levels of expo-
sure and in comparison with ALAD-1 subjects,
heterozygous or homozygous ALAD-2 carriers
demonstrate increased blood lead levels
(Kelada et al. 2001; Scinicariello et al. 2007).
The VDR (vitamin D receptor) genotype has
also been shown to inﬂuence the level of blood
lead. Thus, Haynes et al. (2003) showed that
children with the Ff genotype displayed lower
blood lead levels than did those with the FF
genotype. For exposure to inorganic arsenic,
the AS3MT genotype appears to have a strong
influence on the fraction of the most toxic
metabolite, monomethylated arsenic, in urine
(Meza et al. 2005; Schläwicke Engström et al.
2007). For most other metals, gene–environ-
ment interactions are largely unknown, and
MeHg is no exception. Custodio et al. (2005)
reported that individuals with one variant allele
for either GCLC-129 or GSTP1-114 had
higher Ery-Hg compared with individuals with
other genotypes but similar exposure. To our
knowledge, no other studies regarding gene–
exposure interactions for MeHg have been
performed.
There are several methodologic issues to
take into consideration. Obviously, evaluating
the modiﬁcation of the relationship between
exposure and retention of MeHg by genes
requires accurate estimates of both. Hence, the
first methodologic issue is the choice of an
appropriate exposure marker for MeHg. The
exposure to MeHg depends on both the intake
of fish and the MeHg concentration in the
ﬁsh. Because we could not measure MeHg in
ﬁsh, we had to rely on a proxy. A way to assess
the usefulness of the different options is to look
for correlations with Ery-Hg. The association
between P-PUFA and Ery-Hg was much
stronger than the association between Ery-Hg
and the self-reported variables—total, fat, and
lean ﬁsh intake—in accordance with previous
studies (Custodio et al. 2004; Hallgren et al.
2001), which probably reﬂects the fact that the
number of ﬁsh meals reported is a poor meas-
ure of the amount of ﬁsh consumed. Hence,
we used P-PUFA as an exposure marker, fully
aware of the fact that P-PUFA is a very
imprecise marker. However, this would bias
toward the null. To achieve linearity, P-PUFA
was double ln transformed. However, the dif-
ference in results between ln %PUFA and
double ln %PUFA is not that large. Some
examples on this (ln-transformed PUFA vs.
double ln-transformed PUFA): GSTP1-105,
0.090 versus 0.077; GSTP1-114, 0.054 versus
0.061; and combination GSTP1-105 and
GSTP1-114, 0.030 vs. 0.038.
We found a time trend of decreasing
Ery-Hg. Another study from the same geo-
graphic area also shows that Ery-Hg is declin-
ing, with an average annual decrease of 5.8%
between the years 1990 and 1999 (Wennberg
et al. 2006). Ery-Hg rose with increasing age in
our study. This ﬁnding is probably explained
by more than just higher fish consumption
among elderly; the correlation between age and
Ery-Hg remained after adjustments for
P-PUFA (data not shown). Increasing age may
also be associated with impairment of the
metabolism of MeHg. Indeed, both GSH and
GST levels have been shown to decrease with
age (Voss and Siems 2006).
The second issue is the use of Ery-Hg as a
marker for MeHg retention. Inorganic Hg can,
to some extent, contribute to the levels of Ery-
Hg. However, Ery-Hg is mainly MeHg and is a
good marker of MeHg body burden (Berglund
et al. 2005; International Programme on
Chemical Safety 1990). Part of the inorganic
Hg could be attributed to demethylation of
MeHg during sample treatment and analysis
(Bergdahl et al. 1995; Berglund et al. 2005).
Additionally, the major source of inorganic Hg,
dental amalgam, has decreased signiﬁcantly in
Sweden (National Swedish Board of Social
Welfare 2002; Sundberg et al. 2000), including
in the present region (Wännman et al. 2004).
The third issue regards Hardy-Weinberg
disequilibrium for GCLM-588. The allele fre-
quency reported here is similar to another
study on Danish and Swiss populations where
equilibrium was reported (Tosic et al. 2006).
The preceding gene–environment study for
MeHg with individuals from the same
Genetic variation in GSH-related genes and body burden of MeHg
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Table 4. Multivariate regression model.a
Polymorphism Effect modiﬁcation β5
b p-Value
GCLC-129 (CC vs. CT) 0.67 0.40
GCLM-588 (CC + CT vs. TT) 0.25 0.90
GSTP1-105 (IleIle + IleVal vs. ValVal) 1.8 0.077
GSTP1-114b (AlaAla vs. ValVal + AlaVal) 1.3 0.061
GSTP1-105 and GSTP1-114 combination
0 and 1 variant allele (222) vs. 2 variant alleles (68) 1.5 0.038
GCLC-129 and GSTP1-105
0 and 1 variant allele (249) vs. 2 variant alleles (42) 1.3 0.095
GCLC-129 and GSTP1-114
0 and 1 variant allele (262) vs. 2 variant alleles (27) 1.8 0.091
GCLC-129 and GCLM-588
0 and 1 variant allele (270) vs. 2 variant alleles (20) –1.0 0.41
GCLM-588 and GSTP1-105
0 and 1 variant allele (226) vs. 2 variant alleles (64) 0.33 0.65
GCLM-588 and GSTP1-114
0 and 1 variant allele (262) vs. 2 variant alleles (27) 0.66 0.50
aGenotypes are dichotomized, and referents are denoted last. Ery-Hg is ln transformed, and P-PUFA is double ln trans-
formed. Only the results of the effect modification (genotype*P-PUFA) on Ery-Hg levels are presented. bThe term β5
denotes the difference between the inclinations of the regression slopes for Ery-Hg on P-PUFA. 
Figure 4. Ery-Hg as a function of P-PUFA for differ-
ent GCLM C588T genotypes. The regression lines
do not reﬂect adjustments for age and year of sam-
pling, as does the multivariate regression model
presented in the text. 
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Figure 5. Ery-Hg as a function of P-PUFA for differ-
ent numbers of variant alleles for GSTP1 Ile105Val
and GSTP1 Ala114Val. The regression lines are
aimed at illustrating the general direction of inter-
action; thus, they were not derived from the multi-
variate regression model presented in Table 4. 
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2geographic area (Custodio et al. 2005) also
showed linkage disequilibrium, whereas in
other studies by our group, using the same
methods but in other populations, we observed
equilibrium (Custodio et al. 2004; Jönsson
et al. 2007). This may indicate that the linkage
disequilibrium is population speciﬁc.
The fourth issue concerns multiple testing.
Several genotypes have been analyzed, which
increases the possibility of false-positive ﬁnd-
ings. A false-positive report probability depends
on the subjective prior belief regarding a true
association (Wacholder et al. 2004). We did
not adjust for multiple effect estimation, based
on multiple models for different genotypes.
However, we performed post hoc testing (with
adjustments for multiple testing) when compar-
ing multiple subgroups (genotypes) of a given
SNP. Further, some results should be cau-
tiously interpreted because they were based on
comparisons in groups with small number of
individuals (e.g., the ANOVA results, dividing
the study subjects in three exposure groups).
The present study indicates that the indi-
vidual differences in retention and elimination
of MeHg are partly due to hereditary differ-
ences in genes conjugating and synthesizing
GSH. Individuals with two variant alleles of
the GCLM-588 polymorphism (TT) had
higher Ery-Hg, but there was no evidence of
effect modiﬁcation. The GCLM-588T allele is
associated with lower promoter activity and
lower levels of GSH in plasma (Nakamura
et al. 2002). An effect of the T allele genotype
(CT + TT), giving increased levels of Hg in
blood, plasma, and urine, has been seen for
inorganic Hg (Custodio et al. 2004), which is
also metabolized by conjugation to GSH.
However, we saw similar effects only for the
TT genotype, whereas individuals with the
CT genotype had lower Ery-Hg than did
those with either the TT or CC genotype. It
appears that GCLM does not exhibit an
allele–dose effect. A recessive model appears to
be more plausible, where TT individuals have
higher MeHg compared with carriers of the
other genotypes. Still, this does not explain the
lower levels of the CT genotype.
We found no results in the dual gene com-
binations that included the GCLM-588 poly-
morphism. This was probably because the
individuals with the lowest and those with the
highest Ery-Hg levels (i.e., CT and TT geno-
types) often were classiﬁed in the same group.
The polymorphisms in GSTP1 (Ile105Val
and Ala114Val) separately appear to modify
the levels of Ery-Hg for different levels of
P-PUFA, and the combination of those poly-
morphisms demonstrated a stronger effect than
did each polymorphism alone. Individuals with
zero or one variant allele had a steeper regres-
sion slope compared with individuals with two
variant alleles. This resulted in significantly
higher Ery-Hg at high exposures, which can be
seen in the ANOVA results. No significant
effects were seen at the low-exposure groups for
any polymorphism. The functional impact of
these variants on MeHg remains to be clariﬁed.
However, both amino acid exchanges are in
the active site of the enzyme and inﬂuence the
activity toward different substrates (Ali-Osman
et al. 1997; Sundberg et al. 1998; Zimniak
et al. 1994).
In the study by Custodio et al. (2005),
individuals with one variant allele for either
GCLC-129 or GSTP1-114 had a steeper
regression slope, compared with those with
zero variant alleles. In the present study, an
effect was seen mainly among carriers with
two variant alleles, but carriers with one allele
demonstrated a nonsignificantly shallower
(p = 0.35) regression slope compared with
carriers with zero variant alleles. The individ-
uals in the study of Custodio et al. (2005) had
a lower exposure compared with the individu-
als in our study, which may explain some of
the differences between the studies. The effect
of the genotypes may differ according to the
exposure. Moreover, the genetic effects are
difficult to study at low exposure levels, and
we cannot rule out the possibility that the
finding from the first study may be a false-
positive ﬁnding.
Conclusion
Data from the present study indicate that
hereditary factors influence the metabolism
of MeHg. Two polymorphisms in GSTP1
modified the Ery-Hg levels at high MeHg
exposures, whereas homozygotes for the
GCLM-588 polymorphism had higher
Ery-Hg levels but showed no evidence of
effect modification. However, the mode of
inheritance for the GCLM polymorphism is
not clear and needs to be studied further. We
would like to stress the importance of infor-
mation on genetic impact on MeHg metabo-
lism, because it may mean a difference in
susceptibility to toxic effects, which may
influence the risk assessment and thus the
foundation of preventive actions.
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